NFKB1 and hepatocellular carcinoma: It has also been shown that deoxycholic acid (DCA) can upregulate the expression and release of GOLM1 by activating the nuclear factor-Kappa B (NF-κB) pathway and destroying the Golgi apparatus in chronic liver disease (CLD) and HCC [22].